Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • U vs GSK✓SelectedUSD · GSKU vs GSK performance historyLatest closeAs of-1.76%11/16
Stock and ETF performance explorer

U vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+77.7%
GSK return
+62.7%
Excess return
+15.0%
Maximum drawdown
-67.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-0.1%-1.7%-1.8%
7D+0.9%-1.3%+2.2%+0.8%
30D+28.4%+2.7%+25.7%+28.7%
3M+12.2%+2.7%+9.5%+12.7%
6M+91.0%+3.3%+87.7%+92.0%
YTD+17.5%+6.5%+11.0%+16.9%
1Y+41.3%+10.7%+30.6%+40.2%
All+77.7%+62.7%+15.0%+65.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling